Low-dose aspirin beginning early in pregnancy helps prevent preterm Preeclampsia

News Hour:

Use of low-dose aspirin lowers the risk for preeclampsia among women determined to be at high risk during first-trimester screening, according to a study presented at a meeting of the Fetal Medicine Foundation and published in the New England Journal of Medicine.

Over 1700 high-risk women with singleton pregnancies were randomized to receive 150-mg aspirin or placebo daily from 11–14 weeks’ gestation until 36 weeks. Women were determined to be at high risk (>1 in 100) based on an algorithm that incorporated maternal factors (e.g., age, obstetric history) and biomarkers (e.g., mean arterial pressure, uterine artery pulsatility index). A tenth of participants had a prior pregnancy with preeclampsia.

Pregnant woman having aspirin

The primary outcome — delivery with preeclampsia before 37 weeks’ gestation — occurred in 1.6% of the aspirin group versus 4.3% of the placebo group. Aspirin’s benefits were seen regardless of obstetric history or magnitude of risk at screening. Adverse events did not differ between the groups.

News Hour Correspondent

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts

Why Japan took a long time to go for country lockdown?
Honor Blackman, James Bond actress dies at 94
Ukraine battles forest fire in Chernobyl nuclear zone
Lady Gaga announces star-studded coronavirus benefit telecast
New Zealand demotes minister for coronavirus lockdown breach, extends emergency
Two South Koreans recover from coronavirus after plasma therapy


News of the Month

Scroll Up
%d bloggers like this: